Genelux Corp (GNLX): Total Liabilities
$7.48M
As of 2025-12-31
$10.09M
As of 2026-06-30
-43.4%
3-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.48M | -11.4% | 2026-03-19, Balance as of period end |
| 2024-12-31 | $8.44M | +0.3% | 2026-03-19, Balance as of period end |
| 2023-12-31 | $8.42M | -79.6% | 2025-03-28, Balance as of period end |
| 2022-12-31 | $41.31M | n/a | 2024-03-29, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Genelux Corp (GNLX) | 2025-12-31 | $7.48M | -11.4% |
| Aspire-Lakewood Holdings, Inc. (ASBP) | 2025-12-31 | $7.69M | +355.5% |
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | $813.0K | +17.5% |
| One World Products, Inc. (OWPC) | 2024-12-31 | $5.26M | +35.7% |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $2.71M | +0.3% |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | $2.36M | +36.5% |
| Skinvisible, Inc. (SKVI) | 2025-12-31 | $10.39M | +10.8% |
| Aditxt, Inc. (ADTX) | 2025-12-31 | $12.56M | -47.3% |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | $7.40M | +264.3% |
Compare GNLX, ASBP, TCRT, OWPC side by side · Screen every company in Pharmaceutical Preparations ↗